All Industries

Top Therapeutics Companies

963 Therapeutics companies, sorted by total funding raised.

Anocca
Södertälje, Sweden51–200Biotech, Healthcare
Venture RoundTotal funding$82.8MAug 2025
TreeFrog Therapeutics

Biotech company developing C-Stem technology for scalable stem cell therapy manufacturing.

Bordeaux, FranceBiotech, Therapeutics
Series BTotal funding$82.6MApr 2021
Medmark

Nationwide outpatient provider offering medication-assisted treatment and counseling to help peop...

Lewisville, United StatesDrug Discovery, Healthcare
Growth EquityTotal funding$81.8MAug 2026
Exegenesis Bio

Exegenesis Bio develops gene therapies and oligonucleotide medicines for neurological and ophthal...

Philadelphia, United States201–500Biotech, Therapeutics
Extension RoundTotal funding$80.0MJun 2021
PIONYR ImmunotherapeuticsAcquired

Pionyr Immunotherapeutics is developing cancer immunotherapies that target the tumor microenviron...

South San Francisco, United States51–200Biotech, Healthcare
Corporate RoundTotal funding$80.0MJun 2020
CHRONO THERAPEUTICS, INC.

R&D company with 3 SBIR/STTR awards from Department of Health and Human Services.

Hayward, United States11–50Biotech, Healthcare
Series BTotal funding$79.6MSep 2016
Cure Genetics

Cure Genetics is a Chinese biotech company developing AAV-based gene therapy vectors in partnersh...

Suzhou, China11–50Biotech, Therapeutics
Series BTotal funding$77.0MJan 2022
TP
TetraLogic PharmaceuticalsIPO

TetraLogic Pharmaceuticals (Nasdaq: TLOG) is a clinical-stage biopharmaceutical company focused o...

United States11–50Biotech, Oncology
Extension RoundTotal funding$75.3MSep 2010
ARS PharmaceuticalsIPO

Develops and commercializes neffy, an FDA-approved needle-free epinephrine nasal spray for treati...

San Diego, United States51–200Healthcare, Therapeutics
Series DTotal funding$75.0MAug 2021
Georgiamune

Clinical-stage biotech building a pipeline of immunomodulators that enhance or inhibit immune sig...

Gaithersburg, United States11–50Life Sciences, Biotech
Series ATotal funding$75.0MAug 2023
Precision BioSciencesIPO

Clinical-stage gene editing company developing in vivo therapies using its proprietary ARCUS geno...

Durham, United States51–200Biotech, Genomics
Venture RoundTotal funding$75.0MJun 2022
Spark TherapeuticsAcquired

Spark Therapeutics develops gene therapy treatments for debilitating genetic diseases; acquired b...

Philadelphia, United States201–500Biotech, Therapeutics
Series BTotal funding$72.8MMay 2014
Hydra Biosciences, Inc.Closed

Private biopharmaceuticals company pioneering the discovery of novel drugs using its expertise in...

Cambridge, United States11–50Biotech, Drug Discovery
Series ETotal funding$72.2MMar 2015
Delphia Therapeutics

Delphia is pioneering an entirely new field of cancer biology called activation lethality to adva...

Cambridge, United States11–50Biotech, Therapeutics
Series ATotal funding$67.0MMay 2024
Hillstar Bio

Developing novel precision immunotherapies to revolutionize autoimmune disease treatment

Boston, United States11–50Biotech, Healthcare
Series ATotal funding$67.0MMar 2025
Shasqi

Biotech company using click chemistry to selectively activate cancer drugs at the tumor site, imp...

San Francisco, United States11–50Biotech, Healthcare
GrantTotal funding$65.5MAug 2024
DiscGenics

DiscGenics develops regenerative cell-based biologic drug therapies to alleviate pain and restore...

Salt Lake City, United States11–50Biotech, Healthcare
Series CTotal funding$64.0MAug 2020
VintaBio

VintaBio supports gene therapy product development and manufacturing through an expert team focus...

Philadelphia, United States11–50Biotech, Drug Discovery
Series CTotal funding$64.0MApr 2023
Vivatides Therapeutics

Biotech developing extrahepatic siRNA and ASO delivery platforms for RNA therapeutics beyond the ...

Suzhou, ChinaBiotech, Therapeutics
Series ATotal funding$64.0MApr 2026
Bionaut Labs

Develops microscale wireless micro-robots to deliver therapies and diagnostics to deep body locat...

Los Angeles, United States11–50Biotech, Medical Devices
Extension RoundTotal funding$63.2MFeb 2024
Satsuma PharmaceuticalsIPO
Biotech, Drug Discovery
Series BTotal funding$62.0MApr 2019
Lighthouse Pharmaceuticals

Alzheimer's disease therapeutics

Novato, United States11–50Biotech, Therapeutics
Series ATotal funding$61.2MApr 2026
Elevian

Elevian develops medicines to promote recovery and regeneration, with a lead recombinant protein ...

Newton, United States11–50Biotech, Healthcare
Series ATotal funding$60.5MSep 2021
64x Bio

High throughput design of cells for therapeutics applications.

Brisbane, United States11–50Artificial Intelligence, Healthcare
Series ATotal funding$60.0MJan 2022
89bio

Biopharmaceutical company focused on nonalcoholic steatohepatitis (NASH) and other liver and meta...

San Francisco, United States11–50Biotech, Healthcare
Series ATotal funding$60.0MOct 2018